NL-OMON56925招募中不适用
2-HG spectroscopy in low grade glioma patients treated with vorasidenib - a pilot study - 2-HG MRS and vorasidenib
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Low grade glioma patients (WHO II), either suspected or histologically proven.
- •treated with vorasidenib
- •Signed informed consent.
排除标准
- •Age <18 years old.
- •Contra-indication for MRI.
研究者
相似试验
招募中
不适用
Non-invasive Glioma Characterization Through Molecular ImagingPrimary Brain TumorMalignant GliomaMalignant Primary Brain TumorGliomaBrain TumorNCT03684109University of Miami30
招募中
2 期
MOS2: Low & Anaplastic Grade Glioma Umbrella Study of Molecular Guided TherapieSGrade 2 GliomaGrade 3 GliomaCancer - BrainACTRN12623000096651The University of Sydney57
已完成
不适用
Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG)GliomaNCT00137488AHS Cancer Control Alberta10
进行中（未招募）
不适用
LIQUID BIOPSY IN Low-grade Glioma PatientsGliomaNCT05133154University Hospital, Montpellier50
已完成
不适用
Clinical Development of MR Spectroscopy and Imaging in Brain CancersMalignant GliomasAstrocytomasOligodendrogliomasNCT02731521University of Texas Southwestern Medical Center112